<DOC>
	<DOCNO>NCT02309242</DOCNO>
	<brief_summary>The aim propose project study long-term impact adjuvant systemic multi- agent chemotherapy ( cisplatin , anthracyclines , vincristine , methotrexate , alkylating agent ) survivor ( treated 1992 2014 UZ Leuven ) paediatric bone soft tissue sarcomas neurocognitive functioning .</brief_summary>
	<brief_title>Long Term Neurotoxic Effects Chemotherapy Survivors Bone Soft Tissue Sarcomas . A Retrospective Study</brief_title>
	<detailed_description>The aim propose project study long-term impact adjuvant systemic multi- agent chemotherapy ( cisplatin , anthracyclines , vincristine , methotrexate , alkylating agent ) survivor ( treated 1992 2014 UZ Leuven ) paediatric bone soft tissue sarcomas neurocognitive functioning use neuropsychological test combination advance Magnetic Resonance ( MR ) image technique cross-sectional design . The majority study focus either neuropsychological outcome structural imaging . In project want combine methodology . MR mainly focus microstructural change white matter difference brain connectivity , neuropsychological test assess broad range cognitive functioning . From obtain MR parameter neuropsychological test result , propose study want answer follow research question : 1 . Are subtle difference neurocognitive function behavior relate chemotherapy exposure survivor paediatric bone soft tissue sarcoma ? 2 . Are differences morphological/functional MR parameter could relate subtle cognitive difference cognitive function chemotherapy exposure ? Can detect structural treatment-induced WM injury ? Can see difference brain neural activity/connectivity rest group ? 3 . Is correlation obtain morphological/functional MR parameter neuropsychological test result ? 4 . Is correlation possible difference white matter microstructure gender , age diagnosis duration treatment ? To answer question , implement follow measurement : - From computerize Amsterdam Neuropsychological Tasks ( ANT ) system test simple motor reaction time , sustain , focus divide attention , inhibitory control cognitive flexibility motor coordination . - Specific verbal-auditory memory nonverbal , visual-spatial memory functioning register Children 's Memory Scale ( CMS ) subject young 16 year auditory verbal learn test Rey visual design learn test subject older 16 year . Age-adjusted standardized norm available test . - The BRIEF ( Behavior Rating Inventory Executive Function ) explore executive function school ( 5-17 year ) , work ( +18 year ) home ( 5-17 year +18 year ) environment . - The assessment intellectual functioning consist Wechsler Intelligence Scale Children ( WISC-III ) patient 6 16 year Wechsler Adult Intelligence ( WAIS-III ) adolescent age 17 year old . - Quality life investigate PEDSQL generic version young adult . - The Achenbach questionnaire ( Child Behavior Checklist , Teacher Report Form , Youth Self Report Form , Adult Behavior Checklist , Adult Self Report Form ) item internalize , externalize , total problem fill parent , teacher relative patient . - All participant complete Spielberger State-Trait Anxiety Inventory Beck Depression Inventory-II . Currently , neurocognitive follow-up paediatric bone brain tumour patient ( NKP21/22c , National Cancer Plan Onkelinx ) well child congenital heart disease ( IWT-TBM , 3M110068 ) treat paediatric intensive care unit also base test battery . All test questionnaire extensively describe used quantify neurocognitive development Quality life various paediatric population . The test perform least one year end treatment . MRI image study neural substrate possible neurotoxic effect chemotherapy-treatment Advanced MR neuroimaging technique combination detail cognitive behavioral assessment use . All subject image 3T Philips scanner 32-channel phased-array head coil , locate radiology department UZ Leuven . Neuroimaging consist 3D T1-weighted FLAIR advance diffusion weighted- imaging ( DWI ) , examine white matter ( WM ) microstructure , rest state functional MRI ( rfMRI ) visualize neuronal activity brain rest ( examination eye close ) . 1 . DWI - technique enable visualization characterization WM architecture via self-diffusion water molecule - allow u study potential chemotherapy-induced change WM microstructure . Damage WM structure - example axonal loss demyelination - may change quantitative DWI parameter fractional anisotropy ( FA ) , mean diffusivity ( MD ) diffusion kurtosis . 2. rfMRI us vascular response nearby electrically active neuron indirectly visualize brain activity allow u determine connectivity different brain region rest . The duration propose scan protocol maximum 45 minute . Statistical analysis Neuropsychological performance Performance neurocognitive measure survivor compare age-matched control group use ANOVA simple contrast control reference STAI BDI score covariates . Partial eta square ( hp2 ) compute estimate effect size ( weak effect : ηp²≈0.03 ; moderate : ηp²≈0.06 ; large : ηp²≥0.14 ) . Cohen 's used simple contrast ( small effect : 0.2 &lt; &lt; 0.3 ; medium : 0.3 &lt; &lt; 0.8 ; large : &gt; 0.8 ) . Subsequent analysis conduct neurocognitive measure survivor demonstrate significantly low value age-matched control group . The independent effect predictor ( treatment group , gender , age treatment , duration treatment socioeconomic status ) neuropsychological score analyze repeated measure mixed effect regression model . Imaging State art image analysis approach apply process analyze acquire brain image document difference structural white matter rest state brain activity study group . DTI image process analyzed use explore DTI , in-house develop software voxel-based statistical analysis . Furthermore , performance neurocognitive measure difference FA MD map survivor compare age sex-matched control group use ANOVA simple contrast control reference STAI BDI score covariates . Seed-based analysis independent component analysis ( ICA ) apply analyze rest state fMRI data . The association obtain MRI parameter performance neurocognitive test investigate use ( voxel-based ) correlation analysis . The independent effect predictor ( treatment group , gender , age treatment , duration treatment socioeconomic status ) neuropsychological imaging score analyze repeated measure mixed effect regression model . Sample size power Study subject recruit paediatric haemato-oncology center UZLeuven . We expect recruit 30 patient within time frame project . A healthy control group ( n=30 ) match age gender include . Demographic characteristic social economic , school work status assess . It difficult perform fundamental power calculation , little known impact chemotherapy bone soft tissue sarcomas cognitive functioning far . We expect recruit 30 survivor bone soft tissue sarcoma childhood . If take number account base previous study report white matter FA change cognitive change childhood ALL patient receive chemotherapy , would power 98.54 % detect difference 1 standard deviation cognitive task ( 1-tailed , α=0.05 ) . For white matter FA change , would power 98 % .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<criteria>Inclusion criterion : Survivors paediatric bone soft tissue sarcoma , treated 1992 onwards paediatric haematooncology department UZLeuven accord one follow treatment protocol . *For soft tissue sarcoma : MMT 95 , MMT 98 , RMS2005 NRST2005 *For Ewing sarcoma : EICESS 92 , EuroEwing 99 EuroEwing 2008 *For osteosarcoma : EORTC 80931 Euramos1 protocol There variability treatment regimen , patient group cluster four subgroup : Cisplatin anthracyclines Cisplatin , anthracyclines methotrexate Alkylating agent Alkylating agent anthracyclines Exclusion criterion : Mental retardation document treatment Inability perform test motor sensory deficit Epilepsy Other cognitive disorder Depression Relapse Parameningeal intracranial sarcoma Syndrome ( e.g . Down ) Autologous stemcell transplantation Head/neck/spinal radiotherapy psychopharmaca</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>